Insmed

Insmed Incorporated is a NASDAQ-listed (INSM) global biopharmaceutical company developing and commercializing therapies for people with serious and rare diseases. Its approved medicines include ARIKAYCE (amikacin liposome inhalation suspension) for refractory Mycobacterium avium complex lung disease and BRINSUPRI (brensocatib) for bronchiectasis. The company advances a pipeline across pulmonary, inflammatory, and rare-disease indications and runs early-innovation science platforms in gene therapy with targeted delivery, protein deimmunization, RNA end-joining, and synthetic rescue. Insmed operates patient-facing surfaces such as a clinical-trials portal and an investigator-initiated-research program, but publishes no public developer API, OpenAPI, or developer portal at this time. This profile was surfaced as a Bessemer Venture Partners portfolio lead and enriched with identity and domain-security data only.

Insmed is profiled on the APIs.io network. Tagged areas include Company, Biotech, Biopharmaceutical, Pharmaceuticals, and Healthcare.

Insmed’s developer surface includes support and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechBiopharmaceuticalPharmaceuticalsHealthcareRare DiseaseClinical TrialsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 14.6/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.9 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/insmed: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: insmed
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/insmed.png
name: Insmed
description: Insmed Incorporated is a NASDAQ-listed (INSM) global biopharmaceutical company developing and commercializing
  therapies for people with serious and rare diseases. Its approved medicines include ARIKAYCE (amikacin liposome inhalation
  suspension) for refractory Mycobacterium avium complex lung disease and BRINSUPRI (brensocatib) for bronchiectasis. The
  company advances a pipeline across pulmonary, inflammatory, and rare-disease indications and runs early-innovation science
  platforms in gene therapy with targeted delivery, protein deimmunization, RNA end-joining, and synthetic rescue. Insmed
  operates patient-facing surfaces such as a clinical-trials portal and an investigator-initiated-research program, but publishes
  no public developer API, OpenAPI, or developer portal at this time. This profile was surfaced as a Bessemer Venture Partners
  portfolio lead and enriched with identity and domain-security data only.
url: https://raw.githubusercontent.com/api-evangelist/insmed/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- bessemer-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotech
- Biopharmaceutical
- Pharmaceuticals
- Healthcare
- Rare Disease
- Clinical Trials
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.insmed.com/
- type: PrivacyPolicy
  url: https://www.insmed.com/global-privacy-policy/
- type: TermsOfService
  url: https://www.insmed.com/terms-of-use/
- type: Support
  url: https://insmed.com/contact-us/
- type: DomainSecurity
  url: security/insmed-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence